11.00MMarket Cap-363P/E (TTM)
1.6700High1.5156Low71.45KVolume1.5900Open1.6000Pre Close114.56KTurnover1.12%Turnover RatioLossP/E (Static)6.79MShares10.400052wk High-2.54P/B10.36MFloat Cap1.440052wk Low--Dividend TTM6.40MShs Float203.8900Historical High--Div YieldTTM9.65%Amplitude1.4400Historical Low1.6030Avg Price1Lot Size
Evogene Stock Forum
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
LAV321demonstrated strong results in its third consecutive year of field trials in Europe
REHOVOT, Israel, Nov. 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced significant progress in the development of its LAV321 bio-fungicide, targeti...
Evogene Announces Collaboration With Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
Following a successful first year, Israel Innovation Authority (IIA) approved financing second year of collaboration
HAZEVA and REHOVOT, Israel, Oct. 8, 2024/PRNewswire/ -- Watershed AC ("Watershed", formerly Colors Farm Ltd.), a cutting-edge company in sustainable aquaculture and biote...
37 MINUTES AGO, 7:00 AM EDT
VIA PR NEWSWIRE
The technology aims to reduce application costs, extend shelf life, and prolong bacterial viability after field application
REHOVOT, Israel, Sept. 30, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of ...
No comment yet